Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) FCF Margin Growth (1y) (2011 - 2026)

Analysis

Lemaitre Vascular (LMAT) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 194.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 984.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 641.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 66.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 119.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 1,788.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -177.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -395.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -473.00
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn -1,010.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,010.00
Mar 31, 2026 571.00
Dec 31, 2025 959.00
Sep 30, 2025 2,044.00
Jun 30, 2025 1,563.00
Mar 31, 2025 587.00
Dec 31, 2024 421.00
Sep 30, 2024 22.00
Jun 30, 2024 -429.00
Mar 31, 2024 660.00
Dec 31, 2023 1,249.00
Sep 30, 2023 508.00
Jun 30, 2023 -149.00
Mar 31, 2023 -1,024.00
Dec 31, 2022 -439.00
Sep 30, 2022 -1,432.00
Jun 30, 2022 -123.00
Mar 31, 2022 -342.00
Dec 31, 2021 -2,319.00
Sep 30, 2021 -517.00